Upcoming Events

We are very excited about the return of the 2nd annual meeting with surging interests from pharma, biotechs and device developers who face common challenges with fierce competition, uncertain regulatory environment, and the need to innovate within connectivity space – all of above will impact on the longevity and commerciality of combination products.

The Cell Engager Summit is the only meeting focused on developing multi-specific cell engaging therapies in liquid and solid tumor indications; accelerating early discovery innovation into the clinic.

Overcome safety and toxicity challenges by increasing target specificity and improved cellular trafficking through informed target selection to ensure enhanced efficacy of your cell engager drug.

Discover how to effectively scale complicated manufacturing of multispecific cell engagers to reduce production costs and time whilst ensuring purity and quality of antibodies.

With 22+ hours of content, 2 interactive workshops and over 5 hours of networking with key industry leaders, this conference will focus solely on cell engaging drugs and how to tackle key clinical and commercial challenges.

Join us as we unite experts from across large pharma, innovative biotech and solution and service providers to bring to market safe and effective multi-specific immune cell engaging therapies.

Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.

If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.

Operating in a highly competitive market with complex environmental guidelines, the fine and speciality chemicals industry is currently experiencing a multitude of pressures whilst benefiting from high levels of investment, especially in green and bio-based technologies. With the right mindset and information, the current challenges can be turned into opportunities for innovation and business growth.

Now in its 34th edition, Chemspec Europe 2019 unites an impressive array of experts, scientists, managers and thought-leaders and provides a powerful and well-known industry platform to discuss the latest market trends, technical innovations, business opportunities and regulatory issues in this rapidly changing market.

Exhibitors at the fine and speciality chemicals exhibition are manufacturers, distributors, regulators, equipment suppliers, raw materials suppliers, traders, agents and consultants, featuring the full spectrum of fine and speciality chemicals for various applications and industries: pharmaceuticals, agrochemicals, polymers, food and feed ingredients, flavours and fragrances, pigments and dyes, paints and coatings, household and cleaning chemicals, adhesives and sealants, petrochemicals, leather and textile chemicals, electronics and many others.

Additionally an outstanding conference programme provides further knowledge and insights into major industry developments as well as key strategies adopted by industry leaders to succeed and grow. All visitors and exhibitors are invited to attend free of charge.

Athens, Greece will set a perfect backdrop for CHEST Regional Congress 2019, co-hosted by the Hellenic Thoracic Society and CHEST. Athens attracts hundreds of thousands of people from all over the world every year, and it is easy to understand why. It maintains its historical architecture and traditions while offering all the excitement and modern amenities expected from Greece’s capital city. The energy here will keep you motivated and learning as you review the latest advances in patient care and chest medicine during our world congress.

INTERPHEX Week Japan consists of 4 exhibitions for pharmaceutical technologies - INTERPHEX JAPAN (Manufacturing & Packaging), in-Pharma Japan (Ingredients), BioPharma Expo (Biopharmaceutical R&D to Manufacturing) and PharmaLab Japan: formerly BIOtech Japan (Drug Discovery & Laboratories). INTERPHEX Week Japan 2019 will have 1,280* exhibitors and 300* speakers, making the event as one of the largest pharma industry events in Asia.

ConferenceSeries Ltd is a renowned organization that organizes highly notable pharmaceutical conferences throughout the globe. Currently we are bringing forth “22nd International Conference and Exhibition on Pharmaceutical Formulations” (Formulation 2019) scheduled to be held during July 4-6, 2019 at Valencia, Spain. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical Formulations.

ConferenceSeries Ltd organizes a conference series of 1000+ Global Events inclusive of 1000+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Asia Pacific Pharmaceutical Symposium (APPS) is the annual regional symposium of IPSF APRO. There will be Symposiums, Workshops, Regional Assembly, Campaign, and Social Events. It’s hold in different country by different association every year, and in 2019, HMF AP ITB have a chance to be the host of 18th APPS 2019.  You will have a chance to meet with pharmacy friends from all over Asia Pacific; networking opportunities, learning sessions and together bonding the Pharmily. Be fresh and young!

It is our great pleasure to invite you to participate in the 2nd International Conference on Advances in Neonatal and Pediatric Nutrition (Pediatric Nutrition 2019) which will take place 08-10 July 2019 in Berlin, Germany.

The purpose of the conference is to bring together pediatricians, nutritionists, neonatologists, experts in child development and other specialists to discuss the challenges of the interplay between Nutrition, neonatology and Pediatrics in the pediatric age groups. The meeting will enable the exchange of ideas and knowledge between the different disciplines for facilitating research and clinical interdisciplinary collaborations focusing on neonatology and nutrition.

In order for a new drug or therapy to gain marketing authorization, writers must coordinate with various stakeholders to gather, organize and compile information on new products or processes; interpret data from clinical trials; and find efficient ways to present trial findings. These documents are then submitted to the FDA, EMA and other regulatory authorities for their approval, with very little time to respond to inquiries or provide additional information.

Given the constant evolution of US and international regulations, it is vital that medical writers stay up to date with the ever-changing regulatory landscape and find innovative approaches to managing the writing process to meet deadlines.

The 6th Clinical Regulatory Medical Writing Forum will address recent regulatory changes and feature industry leaders as they discuss process improvement strategies. Return to work armed with the necessary tools and techniques to contend with aggressive deadlines.

The 3rd eRegulatory Submissions Summit examines updates in documentation submissions to regulatory agencies in order to clarify the applications and identify best practices for electronic submissions.

The Regulatory submissions landscape if ever-changing given the obligatory 2018 initiative to make CTD submissions electronic and the 2019 implementation period required for electronic submission of standardized study data. It is essential to ensure the quality and consistency of each document included in a submission to avoid complicating the regulatory submissions process when multiple team members get involved.

The 3rd eRegulatory Submissions Summit will cover changes made to the electronic submission processes and protocols for constructing strategies for IDMP, RIM, global and regulatory submissions. This summit will also address regulatory information management experiences and the standards for the identification of medicinal products and best practices for eCTD submission requirements.

The healthcare (AI) market is to exceed $10 billion by 2024, according to a new report. There will be significant drivers for growth in healthcare AI in the future – such as precision medicine and the need to reduce healthcare costs overall. Data-heavy technology such as genomics research, along with incremental innovation in robotic personal digital assistants could also boost growth according to the report. AI-based medical imaging and diagnosis will see more than 40% growth to more than $2.5 billion by 2024, the report predicted. U.S. healthcare artificial intelligence market was valued over USD 320 million in 2016 and is estimated to witness more than 38% CAGR over the coming years. Drug discovery applications account for over 35% of healthcare artificial intelligence market share, which could see the segment exceed $4 billion in revenue by 2024. Key clinical health AI and machine learning applications can potentially create $150 billion in annual savings for the U.S. healthcare economy by 2026. Revenue in the AI health market is expected to reach $6.6 billion by 2021

The global IoT healthcare market is expected to grow from USD32.4 Bn in 2015 to USD163.2 Bn by 2020, a CAGR of 38.1%. One of the world’s biggest markets for healthcare services, the United States spends approximately 18% of its GDP on healthcare every year. By improving adherence to prescribed therapies alone, the US could significantly reduce their healthcare spends. The effective deployment of IoT-based healthcare delivery technologies could help the US save well over USD 300 billion

Our 2nd Annual Pharma AI & IoT 2019 will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of techonologyy impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies,  our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. This event will provide an important platform for stakeholders to discuss and share best practices in furthering technology development in pharma and healthcare

It gives me great pleasure in welcoming all of you to the Virtue Insight’s 2nd Annual Pharma AI & IoT 2019.

The Pharma MES Asia is the leading knowledge exchange platform for pharma manufacturing in the APAC region, bringing together all stakeholders who play an active role in the pharmaceutical and biotech industries and the life science scene. The event provides you with precise insights into new business prospects and technical strategies while offering you the chance to discuss specific roadmaps for pharma manufacturing and manufacturing execution systems. Discover the next era of Pharma MES – NOW!

Organizing successful conferences has been at the core of ConferenceSeries LLC Ltd. We are delighted to organize the 2nd International Conference on Biological & Pharmaceutical Sciences during July 12-13, 2019 at Yokohama, Japan

The conference is a specially organized two-day event which will provide a multi-channel communication platform that brings together both “producers” and “consumers” of pharma & biological science world of generic sector. It includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. It is a perfect platform for researchers, scientists and, delegates to share experience, foster collaborations across industry and academia, and evaluate emerging technologies across the globe.

Real-world evidence is transforming the healthcare landscape, and the new opportunities and benefits from RWE are endless, but the challenges remain.

Real-world evidence provides significant insight into how a drug or device performs or is used in real-world settings. The ability to quickly transform real-world data sources into evidence can improve health outcomes by helping pharmaceutical organizations be more efficient in drug development and commercialization.

These insights help to better develop therapies quickly, as well as furthering the development of a product’s benefit-risk profile to provide definite evidence for payers and differentiate their brand in the market. Changes at the FDA are also prompt pharmaceutical and life sciences companies to take a hard look in 2018 at their ability to collect and use real-world data. These new real-world evidence partnerships will create revenue streams for cash-strapped health systems or provide resources and technical expertise to extract meaningful population health insights.

ExL is excited to bring you the 3rd Real-World Evidence Forum to bring together the industries leaders at a two-day educational summit where attendees will learn to drive down medical costs and improve both product safety and effectiveness while fulfilling the requests of regulators, payers, healthcare providers, and patients.

The 2019 Drug Pricing and Reimbursement Stakeholder Summit examines the current and future changes to the pricing landscape as it shifts in response to administrative changes.

Given federal and state pricing requirements arising, press releases from industry leading pharma companies, and the new Drug Transparency Act, it is important to stay ahead of news headlines and anticipated requirements in order to hit company profit targets, maintain value to patients and promote strong, multi-beneficial relationships with manufacturers, providers, payers, and all other stakeholders within the pricing landscape.

This conference will provide a platform to encourage a dialogue among such stakeholders in the pricing and reimbursement space so that they can receive a current state of the union regarding regulatory changes while providing actionable insights in anticipation of the future.

Part of the PREDiCT series, the 7th Annual Tumor Models Boston summit continues to act as the focal point for preclinical and translational scientists looking to improve their early stage candidate decision making. Returning for its 7th year, we will be bringing together model developers and pharmaceutical scientists actively seeking to explore how classical and emerging models are evolving strategies supporting efficacy determination, biomarker discovery and combination therapies to the clinic with more confidence.

This year, over 39 Preclinical & Translational Oncology Heads, each pioneering the further development and application of experimental models, will be sharing the latest insights on the impact of their work. Joining them will be 100+ senior level scientists from pharma, model developer and academic labs set to review the comparative cost-per-data point of next generation models alongside classical model-systems.

Indian Pharma Expo (IPE) will provide an opportunity for the participating companies to display their products & services to the gamut of visitors, globally from pharma and healthcare industries. The 3-day expo will bring together eminent personalities from various sectors of pharma, non-pharma and healthcare industries. IPE is one stop juncture to all those who are planning to expand their business through various channels of franchise and distribution; as well as wholesalers and hospital purchase personnels who seek to buy bulk products on concessional rates.

The Industry’s Definitive Meeting to Advance the Development of Clinically Transformative Neuropsychiatric Drugs

With the huge unmet clinical need in neuropsychiatry and despite multiple approved pharmaceuticals available, the development of the next generation of neuropsychiatric drugs is essential.

Historically, drug development within neuropsychiatry has been stifled for decades by a lack of scientific progress in the neuropsychiatric field combined with costly and challenging clinical trials.

The abundance of excitement and scientific progress in the field – especially with the recent approval of esketamine – will be captured at the NPD meeting, as well as unravelling the complexities of developing truly transformative neuropsychiatric drugs.

With 70+ of the field’s thought-leaders uniting from around the world, NPD will be your opportunity to not only gather the latest scientific insights but to discuss, in depth, the challenges that have been stifling the progress of neuropsychiatric drug development such as translatable models, biomarkers and looking to target neuropsychiatry symptomatically.

Join us at NPD to stride towards developing neuropsychiatric drugs to truly transform patient quality of care.

Increasing the Prominence of Women in the Life Sciences Legal Community through Substantive Legal Discussion, Professional Development, and Woman-to-Woman Networking.

Each year, nearly 200 professionals attend this annual event specifically designed for women life sciences practitioners to discuss the challenges and opportunities facing women in this industry, as well as to foster communication between like-minded individuals about the key legal developments for pharmaceutical, biotech, and medical device companies in the life sciences world.

Over the past year, there has been a huge movement across the country and across all industries to ensure women are treated equally in the workplace, highlighted in the media by the Time’s Up movement and #metoo. This year’s program brings together a speaker faculty full of truly inspirational women, coming together to lead you through two days of of-the-moment discussions, substantive legal updates, and concrete tools you can implement immediately. Advice and strategies abound at this one-of-a-kind conference designed specifically to address the needs of women trying to advance and thrive in the Life Sciences field.

PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in your field. Listen to motivating keynotes from thought leaders or rub elbows with pioneers across the globe. Italy is all set for an amazing event as PULSUS proudly presents the “3rd European Pharma and Pharmaceutical Sciences Congress” slatted on July 25-26, 2019 at Rome, Italy.

PULSUS Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity. With a legacy of 30 years of excellence in Medical Publishing, Now, we are running several International Conferences in the fields of Medical, Clinical, Life Science and Pharma.

European Pharma 2019 focuses on the importance to understand drugs and how they can affect human physiology. It is with a better understanding of Pharmacology one can know the right dosage and dosage forms of drugs. More research in pharmacology deals with identifying and responding to drug interactions and its side effects along with its mechanism of action, its therapeutic index and thereby treat accordingly. More intensive study with the interaction between a drug and its therapeutic effect helps to identify the properties of ideal drugs.

The Conference provides the research work of pharmacology and therapeutics from various scientific backgrounds and the same can be perceived by pharmacologists, scientists and students. European Pharma 2019 brings a unique platform for scientists, researchers, academicians, professors, and students to share their knowledge and views also presenting research about the latest pharmacological activities of drugs and chemical properties. PULSUS Group provides an opportunistic environment and vibrant podium through these auspicious events.

Conference Series invites all the participants from all over the world to attend 2ndInternational Conference on Medical & Health Science during July 26-27, 2019 in Melbourne, Australia which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

The aim of our conference is to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere.  Conference Series gathers renowned Physicians, Pharmacists, Scientists, Acupuncture Practitioners, Ayurveda Practitioners, Homeopathy Practitioners, Naturopathic Physicians, Young Researchers, Healthcare Industrial Delegates and Talented Student Communities in the field of Medical Science under a single roof where networking and global partnering happens for the acceleration of future research.   

Cardio 2019 welcomes you to join the 27th International Conference & Exhibition on Cardiology and Cardiovascular Medicine which will be held from July 26-27, 2019 | Kyoto, Japan which includes prompt Keynote Presentations, Oral Talks, Poster  Presentations And Exhibitions.

CHINATRIALS+US is the new annual meeting place for senior clinical development leaders from the top innovative biotechs in China and the US.

The Summit will focus its discussion on identifying the best global development strategies biotechs should adopt to include both China+US markets, enabling them to most effectively and efficiently bring their innovative new therapies to the world's number one and two pharmaceutical markets.

Vaccine Congress 2019 is a global platform to discuss and learn Vaccine,  Immunology, Bacterial Vaccines, HIV/AIDS Vaccines, Toxoid Vaccines, Children Vaccines, Unconventional Vaccines, Vaccine Industry, Protein Based Vaccines, Plant Derived Vaccines, Vaccine Safety & Efficacy, Geriatric Immunization, Immunizations, Vaccines & Immunizations, Cancer Vaccines , Travel Immunization,  DNA Vaccines, HPV Vaccines, Adjuvants & Delivery Technologies, Vaccines Clinical Trials, Viral Vaccines, Antibodies Research, Neonate Vaccines, Immune Mediated Vaccines, Mosquito-Borne Diseases-Vaccines, Human Vaccines, Animal Vaccination, Vaccines Research & Development. Vaccine Congress 2019 is devoted to the advancement and dissemination of new knowledge about all aspects of the immune response in health, in disease, and after vaccination.

The life science and clinical data transparency industry must take a collaborative approach to achieve data disclosure compliance to combat the burden of new regulatory requirements and renewed infrastructure needs. Within these new regulatory changes, both the U.S and global level develop strategies to release patient-level data and anonymous data to achieve meaningful patient engagement.

At ExL’s 3rd Disclosure and Transparency for Clinical Data Summit attendees will gain comprehensive, high-quality education that balances commercial values and ethical responsibility through the execution of national and global data transparency.

The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates.

With an emphasis on biologics, and built with the field's leading minds from the likes of Biogen, Genentech, Armagen & Denali, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development.

Cardiology Congress 2019 Conference will be an investigation of new research Innovation in the field of Cardiology and spread the most recent advancements in heart disease prevention and rehabilitation. Argument on new technology enhancement in the field of Cardiovascular Disease and current practices in cardiovascular therapy, Cardiac progenitor cells, Hypertension for the primary care clinician, Stent procedure, Balloon Valvuloplasty, Coronary thrombectomy, Noninvasive cardiac imaging, Heart failure, Congestive heart failure, Sports Cardiology and more. Differentiating heart disease and other cardiac conditions constitute a team of healthcare professionals, of which the Cardiology technologist is a key player.

CPhI Korea provides a dynamic meeting place for a wide range of industry suppliers to engage with purchasers and decision makers from the pharmaceutical industry in Korea and the surrounding region. The exhibition showcases the whole pharma supply chain from ingredients, contracting services to machinery and biopharmaceuticals, as well as hosting an extensive conference programme covering the latest trends and topics within the regional market.

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.

A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.

Throughout the course of the three day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers from the international pharmaceutical, academic and clinical communities.

Over the past 40 years, biopharmaceutical products have become increasingly important medicinal tools for human and animal healthcare. Recognizing the critical role that manufacturing plays in enabling pharmaceutical innovation and the important synergies connecting different product platforms, PDA Europe will be introducing its inaugural Bio-Manufacturing Conference in Munich/Germany. The conference will provide a forum to present innovative approaches and discuss hot topics related to product, process and analytics spanning a variety of biopharmaceutical product classes.

Experts from industry, academia and regulatory agencies are warmly welcomed to attend this unique event and join the exchange and the abundant networking opportunities. On behalf of PDA Europe and the Scientific Program Planning Committee, we look forward to welcoming you to the beautiful city of Munich!

CoBrCa is a comprehensive congress addressing controversial issues in breast cancer and related topics. Through presentations, debates and discussions, it aims to be the leading forum for opinion leaders, clinicians and the industry to reach the best clinical recommendations for therapeutic dilemmas.

The PREDiCT: 4th Annual 3D Tissue Models Summit will showcase the latest case studies to clarify context of use behind current model selection to advance the success of preclinical drug discovery and disease translation. This year, join us for the latest insight into established validation techniques to increase reproducibility and improve the preclinical effectiveness of drug candidates.

Hear from 25+ world-leading experts from organizations including the FDA, NIH, and IQ Consortia across 3 days for insight into how the key industry partnerships are supporting the development of organoid and tissue-on-chip technology, enhancing the therapeutic success of your preclinical pipeline.

Designed with skin microbiome experts from MatriSys Bioscience, Quorum Innovations, Viome, L’Oréal, Oriflame Cosmetics, Unilever and academics worldwide, this year’s 2nd Microbiome Movement – Skin Health & Dermatology Summit encapsulates the critical scientific challenges and opportunities shared by both microbial-based cosmetic and therapeutic product developers alike. Join us to translate the skin microbiome into safe, effective and commercially viable therapeutics and cosmetic products for improved skin health.

Returning for the 10th year, Clinical Biomarkers & World CDx Boston is once again the home for the biomarker, translational, diagnostic and precision medicine community to enhance the translation and clinical validation of novel predictive biomarkers, and maximize access and adoption of Dx-enabled therapeutics.

Built for the entire precision medicine industry, from pharma and biotech to Dx, HCPs, regulators and payers, Clinical Biomarkers & World CDx Boston will cover end-to-end the translation, clinical implementation and commercialization of a biomarker strategy to increase market penetration and share. Ultimately, the meeting is here to turn biomarker R&D innovation into better utilization of Dx testing in healthcare – to provide patients with the right treatment decision and most effective therapies at the right time.

We bring together the key players from the drug safety community, providing you with an unrivalled opportunity to expose and address the drug safety challenges facing your industry.

This is your perfect opportunity to demonstrate thought leadership and identify and approach new business prospects.

The CAR-TCR Summit celebrates 5 years of bringing together the world’s leaders in innovating, developing and delivering CAR and TCR based immunotherapies to patients globally with a mission to ENGINEER A CANCER FREE WORLD.

The CAR-TCR Summit is world renowned for providing industry leaders with the most up-to-date and comprehensive insight into the full end-to-end drug development chain as well as never-seen-before data from the movers and shakers in the CAR-TCR landscape including Adaptimmune, Endocyte, Celyad, Allogene and many more!

Following the success of the first iCDP summit last year, we are returning this September to provide the primary industry platform for the advancement of cannabinoid-derived pharmaceuticals. When this summit takes place it will have been just over a year since GW Pharmaceutical’s created the first FDA approved drug containing a cannabinoid API, and several contenders are hot on their heels. However, there are many challenges still obstructing the development of this generation of cannabinoid pharmaceuticals.

Join your peers at the 2nd Annual International Cannabinoid-Derived Pharmaceuticals Summit to solve your challenges in this fast growing field, and to maximise the potential of the next-generation of cannabinoid pharmaceuticals.

BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.

With growing demand to create patient-centric, cost-effective and time-efficient clinical trials, Clinical Innovation Partnerships is the only conference bringing together 120+ Clinical Operation and Procurement decision makers.

Walk away with practical insights on how to reap the benefits of AI, blockchain, virtual trials and create clinical trials of the future.

The scale of available health data is increasing rapidly and as the age of Big Data is established, and following the success of the first event, we will be holding the second “Big Data for Pharmacovigilance Conference”.

Pharmacovigilance is increasingly characterised by extremely large data sets from populations, individuals, disease registries, social media, pharmacogenomics and more. While big data can be messy, efforts are underway to establish strategies for ordering and structuring the data in order to put it to the best use in pharmacovigilance and ultimately public health.

LexisConferences consider it a privilege and a matter of great pride to host Conference on Pharmaceutical Nanotechnology & Nanomedicine Congress is to be held at Venice, Italy for the duration of September 13 -14, 2019. On this auspicious occasion, Organizing Committee invites the participants from all over the world to take part in this annual flagship conference with the theme “Exploring the Progress of Nanomedicine with Trending Nanotechnologies”. The conference will provide a forum for interaction among attendees on Pharmaceutical Nanotechnology, Development of Nanotechnology-enabled Devices, Micro Fluidics platform for Nano Particle Synthesis, Toxicology and Risk Assessment of Nanomedicine Systems, Medical Nano Devices and Biosensors, Synthesis of Nanoparticles for Drug Delivery, Nanomedicine for Immune System and Cancer Diagnosis & Therapy.

This global meeting will assemble the world leaders in the expanding fields related to Pharmaceutical Nanotechnology & Nanomedicine. It will create an interface among professionals, academic faculty members, Researchers, Nanotech representatives and students, Nanotechnologists, Manufacturing Medical Device and experts in the fields of Nanotechnology. industry practitioners. The Conference will also have a room for companies and/or institutions to present their services, products, revolutions and research results.

The New Advances in Inflammatory Bowel Disease conference will highlight the latest concepts in the diagnosis and treatment of IBD. Disease complications, special population considerations, and surgical options will also be discussed. The course will be taught by nationally known experts who are actively involved in clinical trials and studies related to the management of Crohn’s and colitis. Physicians will be provided with the necessary context to integrate the relevant information into their practices to improve the quality of life for their afflicted patients.

CPhI Middle East & Africa will be the region's most comprehensive pharma gathering. Together, with its co-located events iCSE, P-MEC, InnoPack and FDF, it will host over 4,900 key visiting pharma suppliers and buyers. With a wide range of exhibitors from all across the entire pharma supply chain, don't miss out on your chance to participate at this unrivalled meeting point in Abu Dhabi.

You’re coming towards the end of your clinical study, but you’re about to face one of the biggest challenges yet… your TMF inspection. This remains one of the most daunting tasks, and there’s no one way to prepare your TMF system, meaning it’s absolutely vital that your system remains regulatory compliant, accurate and complete to ensure you’re taking the best approach possible to ensure audit success, the FIRST time!

Discover how you can optimise your TMF processes by attending the 5th Annual Trial Master Files and Inspection Readiness Summit and be guided through our most interactive programme yet! With focuses on sponsor and CRO oversight, TMF interoperability, eTMF transition and securing senior management support – this event is the only platform where you can benchmark with the principle experts within the TMF industry through a 100% interactive program.

Mobile tools are designed to reduce the burden to patients, collect more accurate data and drive better health outcomes. The 6th Annual Mobile in Clinical Trials event presents the latest progress in applying mobile/digital tools  and patient-facing technologies to connect and empower patients, while obtaining better outcomes in drug development.